CLINICAL_TRIALS
trial_result
· 2022-02-23
Clinical Trial Update: CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer [Phase 1, Phase 2]
Summary
Clinical trials update for CHF6467 in diabetic neuropathic foot ulcers across Phase 1 and Phase 2 have completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Diabetic Neuropathic Foot Ulcers | Phase 1, Phase 2 | Status: COMPLETED